|
|
|
|
|
Product Name
|
Angiotensin Converting Enzyme 1 peptide (Carboxyterminal end catalytic domain)
|
|
Product type
|
Proteins and Peptides
|
|
Peptide
|
Synthetic peptide Angiotensin Converting Enzyme 1.
This peptide was used as an immunogen for ab28313 - Angiotensin Converting Enzyme 1 antibody - Carboxy catalytic domain.
|
|
Specificity
|
We have a range of domain specific antibodies for this target. For a full list please see all Angiotensin Converting Enzyme 1 antibodies
|
|
Tested applications
(see key)
|
ELISA, WB
|
|
Application notes
(see key)
|
Recommended dilutions
ELISA: Use at an assay dependent dilution. WB: Use at an assay dependent dilution. This peptide can be used with studies using ab28313. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Research areas
|
Cancer >> Cancer Metabolism >> Response to hypoxia
Cardiovascular >> Vasculature >> Vasoconstriction >> Other
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Metalloprotease >> ACEs
Signal Transduction >> Metabolism >> Vitamins / Minerals
Stem Cells >> Hematopoietic Progenitors >> Surface Molecules
Cardiovascular >> Blood >> Serum Proteins
|
|
Relevance
|
ACE converts angiotensin I to angiotensin II by release of the terminal His-Leu, this results in an increase of the vasoconstrictor activity of angiotensin. Also able to inactivate bradykinin, a potent vasodilatator. ACE exists in two forms, a 170KD somatic form and a 90KD germinal form. The somatic form is expressed by endothelial cells (especially those of lung capillaries and arterioles), epithelial cells (especially in proximal renal tubules and small intestine), by some neuronal cells and variably by some macrophages and T lymphocytes. The germinal form is expressed by spermatozoa.
|
|
|
Alternative names Angiotensin Converting Enzyme 1 peptide (Carboxyterminal end catalytic domain) (ab41279) |
|
Purity
|
>95% by SDS-PAGE
|
|
Storage buffer
|
Preservative: None
Constituents: 0.001% Tween 20, 30mM HEPES, 2mM EDTA, 150mM Sodium chloride, pH 6.75
|
|
Form
|
Liquid
|
|
Concentration
|
1.000 mg/ml
|
|
Storage instructions
|
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this Angiotensin Converting Enzyme 1 peptide (Carboxyterminal end catalytic domain) is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| |
|
Search PubMed (MEDLINE) for references to Angiotensin Converting Enzyme 1
|
| |
Angiotensin Converting Enzyme 1 peptide (Carboxyterminal end catalytic domain) - more information
|
Customer reviews (feedback) regarding Angiotensin Converting Enzyme 1 peptide (Carboxyterminal end catalytic domain) |
Customer FAQs regarding Angiotensin Converting Enzyme 1 peptide (Carboxyterminal end catalytic domain) |
Protocols for Angiotensin Converting Enzyme 1 peptide (Carboxyterminal end catalytic domain) |
Price and availability of products related to Angiotensin Converting Enzyme 1 peptide (Carboxyterminal end catalytic domain) |
| |
Angiotensin Converting Enzyme 1 peptide (Carboxyterminal end catalytic domain) - related products:
|
|
|
| |
Angiotensin Converting Enzyme 1 peptide (Carboxyterminal end catalytic domain) - other tools:
|
Contact Abcam with a Technical Enquiry about Angiotensin Converting Enzyme 1 peptide (Carboxyterminal end catalytic domain) |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Pricing information loading
